Deal of the Day — limited-time pharmacy picks!
Carbocine 150mg\15ml Injection

Carbocine 150mg\15ml Injection

Prescription requiredRx Required

Salt Composition: Carboplatin

Expiry Date: 01/2028

Special offer

Price on Request

Price on Request

Inclusive of all taxes

▼

1 Injection

About The Product

Ovaries Cancer,  Lung cancer

Description

Carbocine 150mg 150mg/15ml Injection is used in the treatment of ovarian and and small cell lung cancer. This anti-cancer medication is a prescription based Injection that works blocking the PARP enzyme which is responsible for their growth of cancer cells in the body.

Its active ingredient is Carboplatin,. a drug belongs to the antineoplastic agents. The medicine dosage and duration is correctly administered by the healthcare professional to ensure safety and effectiveness of the medication.

Indication

Ovaries and lung cancer

Common Side Effects

• Muscle cramps
• Confusion, visual disturbances, seizures, and headache
• Breathlessness
• Swelling of feet
• Changes in heartbeat
• High blood pressure
• Pneumonia
• Loss of appetite
• Sensitivity, tingling and burning sensation of the skin
• Nausea, vomiting, and diarrhea
• Mouth ulcers
• Constipation

Dosage And Administration

  • Carbocine 15ml Injection can be taken only under the doctor guidance as it may contain harmful side effects that can interrupt with the treatment.
  • The medication should only be taken at the fixed time everyday to enhance the effectiveness of the medication.
  • Doctor prescription is required and patient should follow all medical instructions as guided by the healthcare professional.

Mechanism Of Action

Carbocine 15ml Injection is used as a first line therapy The disease is caused by genetic mutation in DNA. It contains PARP inhibitor drug which blocks the PARP enzyme that is responsible for the production of cancer cells in the body.

It also stops the cancer cells from spreading to other body parts as well. By causing DNA damage, it triggers cancer cells to die through programmed cell death (apoptosis).

Safety Advice

Alcohol
Taking Carbocine 15ml Injection with alcohol is may be dangerous to the patient health but consult the doctor before taking the medication.
Driving
Carbocine 15ml Injection may not cause dizziness or sleepiness but patient may still experience some side effects. It is important to monitor the response of medication and report any unusual symptoms to the doctor.
Pregnancy
Carbocine 15ml Injection is not recommended to pregnant and breastfeeding women as it may affect the fetus or newborn. Take guidance from a healthcare expert to ensure safety and precautions.
Kidney
Kidney patients should take precautions while using Crarocine 15ml Injection, as dose adjustment and doctor's prescription is much needed.
Liver
Liver patients should take precautions while using Crarocine 15ml Injection, as dose adjustment and a doctor's prescription is much needed.

Faqs

Crabocine treats ovarian and non small cell lung cancer by blocking the DNA mutation and slow the cancer cell progression in the body.

References

  • Wagstaff, A. J., Ward, A., Benfield, P., & Heel, R. C. (1989). Carboplatin: a preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of cancer. Drugs, 37(2), 162-190. https://pubmed.ncbi.nlm.nih.gov/2649354/
  • Sousa, G. F. D., Wlodarczyk, S. R., & Monteiro, G. (2014). Carboplatin: molecular mechanisms of action associated with chemoresistance. Brazilian Journal of Pharmaceutical Sciences, 50(4), 693-701. https://www.scielo.br/j/bjps/a/9F6tZpxsm7spMKjGn6Z3kvr/?lang=en
  • Go, R. S., & Adjei, A. A. (1999). Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin. Journal of Clinical Oncology, 17(1), 409-409. https://pubmed.ncbi.nlm.nih.gov/10458260/
  • Douple, E. B., Richmond, R. C., O'Hara, J. A., & Coughlin, C. T. (1985). Carboplatin as a potentiator of radiation therapy. Cancer treatment reviews, 12, 111-124. https://pubmed.ncbi.nlm.nih.gov/3910216/
  • Stewart, D. J. (2007). Mechanisms of resistance to cisplatin and carboplatin. Critical reviews in oncology/hematology, 63(1), 12-31. https://pubmed.ncbi.nlm.nih.gov/17336087/

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026